No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AFIB Acutus Medical
- 0.1700
- -0.0045-2.58%
Close Apr 19 16:00 ET
- 0.1702
- +0.0002+0.12%
Post 19:02 ET
5.05MMarket Cap-60P/E (TTM)
0.1751High0.1648Low402.40KVolume0.1730Open0.1745Pre Close68.27KTurnover1.72%Turnover RatioLossP/E (Static)29.72MShares1.089952wk High-5.67P/B3.98MFloat Cap0.160052wk Low--Dividend TTM23.42MShs Float38.9900Historical High--Div YieldTTM5.90%Amplitude0.1600Historical Low0.1690Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Earlier Announced, Acutus Medical Was Granted EU Patent #3294412 For "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information"
Acutus Medical Full Year 2023 Earnings: US$0.41 Loss per Share (Vs US$1.40 Loss in FY 2022)
Acutus Medical GAAP EPS of -$2.81, Revenue of $7.2M
Acutus Medical 4Q Rev $2.4M >AFIB
Acutus Medical 4Q Rev $2.4M >AFIB
Acutus Medical: Due to Plan to Realign Resources to Support Left-Heart Access Distribution Business and Exit From Electrophysiology Mapping and Ablation Businesses, Co Will No Longer Provide Fincl Guidance >AFIB
Acutus Medical: Due to Plan to Realign Resources to Support Left-Heart Access Distribution Business and Exit From Electrophysiology Mapping and Ablation Businesses, Co Will No Longer Provide Fincl Gui
Press Release: Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB) today r
Comments
$Acutus Medical(AFIB.US$ why no one care :(
Hehehe!
$Acutus Medical(AFIB.US$ Acutus Medical Has Been Granted European Patent Number EP3294412 Titled "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information (For Diagnosis And Treatment Of Cardiac Abnormalities)"
$Acutus Medical(AFIB.US$ good news, but not up that much
Despite Acutus Medical's strong revenue growth, its low price-to-sales ratio suggests perceived future risks. The company's higher than industry forecast growth indicates potential underlying risks to future performance.
Acutus Medical's New Milestone: European Patent EP3294399 for Innovative Catheter System.
In a significant stride forward for the medical technology sector, Acutus Medical (NASDAQ: AFIB), a dynamic arrhythmia care company, has been granted the European patent number EP3294399. The patent is titled "Catheter System for Left Heart Access," signifying a breakthrough in cardiology treatments and procedures.
https://stockregion.app/p/medical-technology-company-secures
https://stockregion.app/p/medical-technology-company-secures
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg